arrow
W

Wei-Pang Chung

National Cheng Kung University
H指数:16
被引数:1,986

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A randomized, multicenter, open-label, phase 2 basket study of CYP11A1 inhibitor opevesostat in participants with selected solid tumors: Study design of cohorts B and C of OMAHA-015

一项关于CYP11A1抑制剂opevesostat在选定实体瘤患者中的随机、多中心、开放标签、II期篮式研究:OMAHA-015研究方案中B组和C组的研究设计

2026-05-010
PRE
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial

曲妥珠单抗deruxtecan与曲妥珠单抗emtansine在HER2-positive转移性乳腺癌脑转移患者中的随机DESTINY-Breast03试验

2024-05-0116
OAAI
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: Updated survival results of the randomized, phase 3 study DESTINY-Breast03
2023-03-015
PRE